ArticleCell death & disease2021

KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer.

Dingheng Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.